Widening the net
Posted: Thu Jun 04, 2026 4:08 pm
Since the MIpact study is multinational I thought it might be interesting to see what other contributing centers might have in their registries. I posed this question. I have pages of data as a result and since some are experiencing data fatigue I will only post the question to Claude.
The recent Kuykendall poster at ASCO showed an unexpected prolongation of OS in MF patients. Can you compare this data to other data sets in non US registries? Especially since 2019 What is an accepted R/R to JAKi os for MF
The recent Kuykendall poster at ASCO showed an unexpected prolongation of OS in MF patients. Can you compare this data to other data sets in non US registries? Especially since 2019 What is an accepted R/R to JAKi os for MF